The Raiders Are Sincere, But Can't Get It Done in Arrowhead
The Las Vegas Raiders lost to the Kansas City Chiefs for the second time this season. Missed opportunities were again the ...
Arrowhead: The Sarepta Partnership Validates RNAi Platform And Reduces Risk
Arrowhead Pharmaceuticals' stock rallied 17% due to significant pipeline developments and strategic partnerships. Learn more ...
Chiefs vs. Raiders: Patrick Mahomes, Travis Kelce make stylish entrance at Arrowhead Stadium
See what Patrick Mahomes, Travis Kelce, and other #Chiefs stars wore to Arrowhead Stadium ahead of Kansas City’s matchup ...
Arrowhead Pharmaceuticals Shares Are On The Rise Today: What's Going On?
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) shares are trading higher Tuesday after the company announced a global ...
Christmas in July: How the Chiefs’ Arrowhead Stadium became the setting of Hallmark’s biggest movie yet
While on set of “Holiday Touchdown,” Hallmark and the Kansas City Chiefs’ football romance, TODAY learned from those behind ...
BioPharma Dive2d
Sarepta rebuilds drug pipeline with Arrowhead deal
A broad licensing and research alliance will hand Sarepta four clinical-stage candidates, while Arrowhead receives $500 ...
Stocktwits on MSN2d
Arrowhead, Sarepta Stocks Rise Despite Price-Target Cuts Post $1B Licensing Deal: Retail Buzz Strong
($ARWR) and Sarepta Therapeutics Inc. ($SRPT) climbed on Wednesday despite Wall Street trimming price targets after the ...
FierceBiotech4d
Sarepta pays $500M cash for rights to 'multiple potential blockbusters' from Arrowhead
Sarepta Therapeutics is paying Arrowhead Pharmaceuticals $500 million in cash, plus a $325 million equity investment, for ...